These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 33997691)
1. Safety and improved efficacy signals following gene therapy in childhood blindness caused by Jacobson SG; Cideciyan AV; Ho AC; Peshenko IV; Garafalo AV; Roman AJ; Sumaroka A; Wu V; Krishnan AK; Sheplock R; Boye SL; Dizhoor AM; Boye SE iScience; 2021 May; 24(5):102409. PubMed ID: 33997691 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Jacobson SG; Cideciyan AV; Ratnakaram R; Heon E; Schwartz SB; Roman AJ; Peden MC; Aleman TS; Boye SL; Sumaroka A; Conlon TJ; Calcedo R; Pang JJ; Erger KE; Olivares MB; Mullins CL; Swider M; Kaushal S; Feuer WJ; Iannaccone A; Fishman GA; Stone EM; Byrne BJ; Hauswirth WW Arch Ophthalmol; 2012 Jan; 130(1):9-24. PubMed ID: 21911650 [TBL] [Abstract][Full Text] [Related]
3. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2. Testa F; Maguire AM; Rossi S; Pierce EA; Melillo P; Marshall K; Banfi S; Surace EM; Sun J; Acerra C; Wright JF; Wellman J; High KA; Auricchio A; Bennett J; Simonelli F Ophthalmology; 2013 Jun; 120(6):1283-91. PubMed ID: 23474247 [TBL] [Abstract][Full Text] [Related]
4. The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene. Hahn LC; Georgiou M; Almushattat H; van Schooneveld MJ; de Carvalho ER; Wesseling NL; Ten Brink JB; Florijn RJ; Lissenberg-Witte BI; Strubbe I; van Cauwenbergh C; de Zaeytijd J; Walraedt S; de Baere E; Mukherjee R; McKibbin M; Meester-Smoor MA; Thiadens AAHJ; Al-Khuzaei S; Akyol E; Lotery AJ; van Genderen MM; Ossewaarde-van Norel J; van den Born LI; Hoyng CB; Klaver CCW; Downes SM; Bergen AA; Leroy BP; Michaelides M; Boon CJF Ophthalmol Retina; 2022 Aug; 6(8):711-722. PubMed ID: 35314386 [TBL] [Abstract][Full Text] [Related]
5. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912 [TBL] [Abstract][Full Text] [Related]
6. Expanded Retinal Disease Spectrum Associated With Autosomal Recessive Mutations in GUCY2D. Stunkel ML; Brodie SE; Cideciyan AV; Pfeifer WL; Kennedy EL; Stone EM; Jacobson SG; Drack AV Am J Ophthalmol; 2018 Jun; 190():58-68. PubMed ID: 29559409 [TBL] [Abstract][Full Text] [Related]
7. Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations. Jacobson SG; Cideciyan AV; Sumaroka A; Roman AJ; Charng J; Lu M; Choudhury S; Schwartz SB; Heon E; Fishman GA; Boye SE Am J Ophthalmol; 2017 May; 177():44-57. PubMed ID: 28212877 [TBL] [Abstract][Full Text] [Related]
8. Long-term preservation of cones and improvement in visual function following gene therapy in a mouse model of leber congenital amaurosis caused by guanylate cyclase-1 deficiency. Mihelec M; Pearson RA; Robbie SJ; Buch PK; Azam SA; Bainbridge JW; Smith AJ; Ali RR Hum Gene Ther; 2011 Oct; 22(10):1179-90. PubMed ID: 21671801 [TBL] [Abstract][Full Text] [Related]
9. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy. Weleber RG; Pennesi ME; Wilson DJ; Kaushal S; Erker LR; Jensen L; McBride MT; Flotte TR; Humphries M; Calcedo R; Hauswirth WW; Chulay JD; Stout JT Ophthalmology; 2016 Jul; 123(7):1606-20. PubMed ID: 27102010 [TBL] [Abstract][Full Text] [Related]
10. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Bennett J; Wellman J; Marshall KA; McCague S; Ashtari M; DiStefano-Pappas J; Elci OU; Chung DC; Sun J; Wright JF; Cross DR; Aravand P; Cyckowski LL; Bennicelli JL; Mingozzi F; Auricchio A; Pierce EA; Ruggiero J; Leroy BP; Simonelli F; High KA; Maguire AM Lancet; 2016 Aug; 388(10045):661-72. PubMed ID: 27375040 [TBL] [Abstract][Full Text] [Related]
11. Leber Congenital Amaurosis Due to Jacobson SG; Cideciyan AV; Sumaroka A; Roman AJ; Wu V; Swider M; Sheplock R; Krishnan AK; Garafalo AV Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670772 [TBL] [Abstract][Full Text] [Related]
12. GUCY2D-Associated Leber Congenital Amaurosis: A Retrospective Natural History Study in Preparation for Trials of Novel Therapies. Bouzia Z; Georgiou M; Hull S; Robson AG; Fujinami K; Rotsos T; Pontikos N; Arno G; Webster AR; Hardcastle AJ; Fiorentino A; Michaelides M Am J Ophthalmol; 2020 Feb; 210():59-70. PubMed ID: 31704230 [TBL] [Abstract][Full Text] [Related]
13. Functional study of two biochemically unusual mutations in Boye SL; Olshevskaya EV; Peshenko IV; McCullough KT; Boye SE; Dizhoor AM Mol Vis; 2016; 22():1342-1351. PubMed ID: 27881908 [TBL] [Abstract][Full Text] [Related]
14. Gene Therapy Fully Restores Vision to the All-Cone Nrl(-/-) Gucy2e(-/-) Mouse Model of Leber Congenital Amaurosis-1. Boye SL; Peterson JJ; Choudhury S; Min SH; Ruan Q; McCullough KT; Zhang Z; Olshevskaya EV; Peshenko IV; Hauswirth WW; Ding XQ; Dizhoor AM; Boye SE Hum Gene Ther; 2015 Sep; 26(9):575-92. PubMed ID: 26247368 [TBL] [Abstract][Full Text] [Related]
15. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial. Fischer MD; Michalakis S; Wilhelm B; Zobor D; Muehlfriedel R; Kohl S; Weisschuh N; Ochakovski GA; Klein R; Schoen C; Sothilingam V; Garcia-Garrido M; Kuehlewein L; Kahle N; Werner A; Dauletbekov D; Paquet-Durand F; Tsang S; Martus P; Peters T; Seeliger M; Bartz-Schmidt KU; Ueffing M; Zrenner E; Biel M; Wissinger B JAMA Ophthalmol; 2020 Jun; 138(6):643-651. PubMed ID: 32352493 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive Genotyping and Phenotyping Analysis of GUCY2D-Associated Rod- and Cone-Dominated Dystrophies. Rodilla C; Martín-Merida I; Blanco-Kelly F; Trujillo-Tiebas MJ; Avila-Fernandez A; Riveiro-Alvarez R; Del Pozo-Valero M; Perea-Romero I; Swafiri ST; Zurita O; Villaverde C; López MÁ; Romero R; Iancu IF; Núñez-Moreno G; Jiménez-Rolando B; Martin-Gutierrez MP; Carreño E; Minguez P; García-Sandoval B; Ayuso C; Corton M Am J Ophthalmol; 2023 Oct; 254():87-103. PubMed ID: 37327959 [TBL] [Abstract][Full Text] [Related]
17. Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants. Jacobson SG; Cideciyan AV; Peshenko IV; Sumaroka A; Olshevskaya EV; Cao L; Schwartz SB; Roman AJ; Olivares MB; Sadigh S; Yau KW; Heon E; Stone EM; Dizhoor AM Hum Mol Genet; 2013 Jan; 22(1):168-83. PubMed ID: 23035049 [TBL] [Abstract][Full Text] [Related]
18. Preclinical studies in support of phase I/II clinical trials to treat Boye SL; O'Riordan C; Morris J; Lukason M; Compton D; Baek R; Elmore DM; Peterson JJ; Fajardo D; McCullough KT; Scaria A; McVie-Wylie A; Boye SE Mol Ther Methods Clin Dev; 2023 Mar; 28():129-145. PubMed ID: 36654798 [TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep. Gootwine E; Ofri R; Banin E; Obolensky A; Averbukh E; Ezra-Elia R; Ross M; Honig H; Rosov A; Yamin E; Ye GJ; Knop DR; Robinson PM; Chulay JD; Shearman MS Hum Gene Ther Clin Dev; 2017 Jun; 28(2):96-107. PubMed ID: 28478700 [TBL] [Abstract][Full Text] [Related]
20. Variants at codon 838 in the Sun Z; Wu S; Zhu T; Li H; Wei X; Du H; Sui R Ophthalmic Genet; 2020 Dec; 41(6):548-555. PubMed ID: 32811265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]